ROD CONE DYSTROPHY
Clinical trials for ROD CONE DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new ROD CONE DYSTROPHY trials appear
Sign up with your email to follow new studies for ROD CONE DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy aims to restore sight in rare eye diseases
Disease control Recruiting nowThis study tests OpCT-001, a therapy made from special cells that may replace damaged light-sensing cells in the eye. It is for adults with inherited eye diseases like retinitis pigmentosa and Usher syndrome. The goal is to check safety and see if it can improve vision. About 54 …
Matched conditions: ROD CONE DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: BlueRock Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New eye imaging study aims to spot retinal disease early
Knowledge-focused Recruiting nowThis study uses a special camera called adaptive optics to take detailed pictures of the back of the eye in people with outer retinal diseases, such as age-related macular degeneration and retinitis pigmentosa. The goal is to develop new ways to diagnose and track these diseases.…
Matched conditions: ROD CONE DYSTROPHY
Sponsor: Food and Drug Administration (FDA) • Aim: Knowledge-focused
Last updated May 17, 2026 10:38 UTC